The latest Office for National Statistics (ONS) survey, ‘Ownership of UK quoted shares: 2016’, shows that retail investors are more important than most company managements realise or most capital markets professionals admit. When it is also appreciated that the data shows that retail investors set the share price for most quoted companies, most days, it becomes clear that engaging with such an audience enhances a company’s standing, whilst ignoring them courts disaster.
09 Jan 2018
The Monthly
Time Finance plc (TIME:LON), 24.8 | Abzena (ABZA:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 43.5 | Allergy Therapeutics plc (AGY:LON), 19.8 | Alliance Pharma plc (APH:LON), 86.6 | Arbuthnot Banking Group PLC (ARBB:LON), 875 | Avacta Group PLC (AVCT:LON), 126 | Burford Capital Limited (BUR:LON), 648 | Chamberlin plc (CMH:LON), 7.0 | City of London Investment Group PLC (CLIG:LON), 450 | Diurnal Group plc (DNL:LON), 62.0 | Evgen Pharma Plc (EVG:LON), 10.0 | Genedrive Plc (GDR:LON), 39.5 | Inland Homes PLC (INL:LON), 58.0 | Morses Club Plc (MCL:LON), 59.0 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 3.4 | Woodbois Limited (WBI:LON), 3.0 | Omega Diagnostics Group PLC (ODX:LON), 52.5 | PPHE Hotel Group Limited (PPH:LON), 1,345 | Yourgene Health Plc (YGEN:LON), 14.2 | R.E.A. Holdings plc (RE:LON), 59.2 | Redx Pharma Plc (REDX:LON), 57.5 | Scancell Holdings Plc (SCLP:LON), 15.8 | Surface Transforms plc (SCE:LON), 61.0 | 600 Group PLC (SIXH:LON), 8.4 | Tissue Regenix Group plc (TRX:LON), 0.5 | Titon Holdings Plc (TON:LON), 110 | Oxford BioMedica plc (OXB:LON), 934
-
-
-
Martin Hall
-
52 pages
-


Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
The Monthly
Time Finance plc (TIME:LON), 24.8 | Abzena (ABZA:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 43.5 | Allergy Therapeutics plc (AGY:LON), 19.8 | Alliance Pharma plc (APH:LON), 86.6 | Arbuthnot Banking Group PLC (ARBB:LON), 875 | Avacta Group PLC (AVCT:LON), 126 | Burford Capital Limited (BUR:LON), 648 | Chamberlin plc (CMH:LON), 7.0 | City of London Investment Group PLC (CLIG:LON), 450 | Diurnal Group plc (DNL:LON), 62.0 | Evgen Pharma Plc (EVG:LON), 10.0 | Genedrive Plc (GDR:LON), 39.5 | Inland Homes PLC (INL:LON), 58.0 | Morses Club Plc (MCL:LON), 59.0 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 3.4 | Woodbois Limited (WBI:LON), 3.0 | Omega Diagnostics Group PLC (ODX:LON), 52.5 | PPHE Hotel Group Limited (PPH:LON), 1,345 | Yourgene Health Plc (YGEN:LON), 14.2 | R.E.A. Holdings plc (RE:LON), 59.2 | Redx Pharma Plc (REDX:LON), 57.5 | Scancell Holdings Plc (SCLP:LON), 15.8 | Surface Transforms plc (SCE:LON), 61.0 | 600 Group PLC (SIXH:LON), 8.4 | Tissue Regenix Group plc (TRX:LON), 0.5 | Titon Holdings Plc (TON:LON), 110 | Oxford BioMedica plc (OXB:LON), 934
- Published:
09 Jan 2018 -
Author:
Martin Hall -
Pages:
52 -
The latest Office for National Statistics (ONS) survey, ‘Ownership of UK quoted shares: 2016’, shows that retail investors are more important than most company managements realise or most capital markets professionals admit. When it is also appreciated that the data shows that retail investors set the share price for most quoted companies, most days, it becomes clear that engaging with such an audience enhances a company’s standing, whilst ignoring them courts disaster.